The recent, increasing amount of knowledge regarding lung cancer, especially in the field of basic science, holds promise for personalized treatment of these patients that would provide more effective and less toxic therapeutic approaches, improving the prognosis of the patients with thoracic malignancies. On the other hand, the immense bulk and the rapid recycling of the new information makes difficult its understanding, evaluation and interpretation by the clinicians. Therefore, the “translation” of our recently acquired knowledge from the lab bench to the bedside is neither smooth nor is it without obstructions, due to the existing “gaps” in our understanding and the often contradictory “signals” from clinical trials.
The success of our two previous meetings has prompted us to organize the 3rd Lung Cancer Network: “From the Bench to Bedside”. Our aim is to narrow the distance between the bench lab and the patient’s bed, between the clinical trials outcome and the routine practice, by bringing together basic scientists, clinical researchers and lung cancer specialists. Our multidisciplinary, international faculty will present the latest clinical data and provide treating physicians with practical information regarding the clinical significance of the histological, molecular and genetic profile of the tumor and how the implementation of targeted agents in the therapeutic algorithm changes the clinical practice of lung cancer patients.
Finally, we anticipate that our meeting, with the presence of our distinguished faculty, would provide the opportunity and motivation for discussions regarding the emerging therapies and set the pavement for the future research and strategies towards the personalized treatment of lung cancer patients.
We cordially welcome you all in Athens in January 31st & February 1st 2014 for a stimulating, innovative and educational meeting.
The meeting is designed for medical, radiation and surgical oncologists, pathologists, chest physicians, scientists, residents-in-training, fellows and other health care professionals interested in the basic and clinical research as well as in the management of thoracic cancers.
CME ACCREDITATION - AUSPICE
The content of the meeting will be submitted for CME accreditation and we will request the auspice of ESMO, IASLC, ETOP.
The Chairs of the Meeting
Professor Kostas Syrigos Professor Alex Adjei Professor Rolf Stahel
September 25th 2013
E.T.S. Events & Travel Solutions S.A.
154 El. Venizelou Str
N. Smyrni, Athens, Greece, 171 22
Tel.: +30 210 98 80 032
Fax.: +30 210 98 81 303